New Medicines, Novel Insights: Accelerating development of cell and gene therapies

Cell and gene therapies offer extraordinary hope to patients with advanced cancers and genetic diseases but pose unprecedented challenges for sponsors. In this report, Parexel experts share insights that can bring these complex treatments to market faster and more efficiently.

Explore the report

Return to Insights Center

Related Insights

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Report

New Medicines, Novel Insights: Achieving patient-guided drug development

Oct 30, 2023

Video

Part 2: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Whitepaper

The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations

Mar 9, 2023

Blog

Celebrating 40 Years of Rare Disease Progress: WODC Highlights

Jun 6, 2023

Article

Three ways to work with the FDA for better patient-focused trials

Jul 29, 2021

Blog

Including patients in DCT design

Sep 13, 2022

Article

Part 1 - Preparing for a Risk-Based Future: What ICH Revisions Mean for Clinical Trial Design and Conduct

Sep 14, 2021

Podcast

CAR-T boxed warnings: What comes next?

Mar 6, 2024

Blog

CAR-T product development: an assessment of FDA’s final guidance for industry

Feb 27, 2024

Article

Near-term strategies for biotech drug developers facing shifting healthcare dynamics

Feb 14, 2024

Blog

A patient-centric approach to managing clinical trial complexity

Jul 13, 2021